LONG FORM GENERIC LETTER FOR PUBLIC COMMENT: SUPPORT FOR RESCHEDULING MARIJUANA TO SCHEDULE III
YOUR NAME YOUR ADDRESS CITY, STATE, ZIP CODE EMAIL ADDRESS DATE
Drug Enforcement Administration Attn: DEA Federal Register Representative/DPW 8701 Morrissette Drive Springfield, Virginia 22152
RE: DOCKET NO. DEA 2024 0059 000
Dear Sir/Madam
I am writing to express my support for the rescheduling of marijuana to Schedule III under the Controlled Substances Act, as proposed in the DEA Rescheduling Draft Docket No. DEA-1362; A.G. Order No. 5931-2024. Below are the key reasons for supporting this change:
LOWER POTENTIAL FOR ABUSE
Marijuana has been found to have a lower potential for abuse compared to substances in Schedule I and II. Scientific studies and epidemiological data indicate that marijuana's abuse potential is significantly lower than that of drugs like heroin and cocaine, justifying
its placement in Schedule III. ACCEPTED MEDICAL USE
Marijuana has a currently accepted medical use in the United States, as recognized by the Department of Health and Human Services (HHS). It is used in state-authorized medical programs to treat various conditions, such as chronic pain, nausea, and more,
demonstrating its therapeutic benefits. SAFETY UNDER MEDICAL SUPERVISION
Marijuana has an acceptable safety profile when used under medical supervision. Rescheduling to Schedule III will ensure that necessary regulatory controls are in place, allowing for safe medical use while minimizing risks associated with misuse and abuse. LIMITED DEPENDENCE LIABILITY The potential for physical and psychological dependence on marijuana is moderate to low. Withdrawal symptoms are generally mild, further supporting the appropriateness of Schedule III classification, where drugs have a lower potential for abuse and dependence compared to Schedules I and II.
PAGE 11
Made with FlippingBook - professional solution for displaying marketing and sales documents online